scorecardresearch
Thursday, May 9, 2024
TopicSerum Institute India

Topic: Serum Institute India

Alleging serious side-effects, vaccine trial participant seeks Rs 5 cr from Serum Institute

Chennai-based participant also sends legal notice to ICMR, DCGI, AstraZeneca & Oxford University to stop testing, manufacturing & distributing vaccine.

AstraZeneca Covid vaccine effective, Indian trials running smoothly, says Serum Institute

The comments came after AstraZeneca & Oxford University acknowledged a manufacturing error that is raising doubts about preliminary results of their experimental Covid-19 vaccine.

Serum Institute, ICMR complete enrolment for phase 3 trials of Oxford Covid vaccine

SII and ICMR are currently conducting phase 2/3 clinical trials at 15 different centres across the country, with 1,600 participants.

Who should be first in line for India’s Covid vaccine? Lal Bahadur Shastri gave us a clue

Health Minister Harsh Vardhan has said that 250 million Indians would be covered with a two-dose Covid-19 vaccine by July 2021.

Oxford vaccine trials running ‘smoothly’ in India, no adverse side-effects so far

In India, trials of the Oxford-AstraZeneca vaccine are being carried out by the Pune-based Serum Institute of India (SII) at 17 sites.

Serum Institute will deliver 10 crore more doses of Covid vaccine to India, other countries

Pune-based Serum Institute of India has already committed to supplying 10 crore doses of the vaccine at a price of about Rs 225 per dose.

Will govt have Rs 80,000 crore to buy, distribute Covid vaccine, asks Serum Institute CEO

Adar Poonawalla said there was a need to plan and guide vaccine manufacturers on procurement and distribution methods.

Phase-3 trial of Oxford vaccine to begin in Pune next week, volunteers start enrolling

Earlier this month, the Serum Institute of India had paused the clinical trials of Oxford vaccine candidate in India. On 15 September, the DCGI gave permission to resume the trial.

Serum Institute gets DCGI nod to resume India’s Oxford vaccine trials, but with conditions

The Serum Institute of India was asked to pause recruitment for the drug trials on 11 September after AstraZeneca paused its trials due to a UK participant fell ill during the study.

Serum Institute to resume trials of AstraZeneca’s Covid vaccine after DCGI nod

AstraZeneca said clinical trials for the AstraZeneca Oxford Covid vaccine had resumed in UK following confirmation by the Medicines Health Regulatory Authority that trials were safe.

On Camera

CEA Nageswaran says India’s FY24 growth could hit 8%, but World Bank warns this is ‘above potential’

Speaking at an event, World Bank country director Auguste Tano Kouamé said growth above potential would result in high inflation.

Three Indian Navy ships deployed to South China Sea

Deployment comes at a time when Yuan Wang 03, a Chinese missile and satellite tracking vessel, has entered Indian Ocean Region.

Frontrunner is letting the challenger define this poll campaign. Modi still hasn’t found a big theme

A theme has not yet emerged for BJP & people see lack of a contest, which makes it unexciting. For all these reasons, 2024 is turning out to be an unexpectedly theme-less election.